Treatment of cancers
US7507766B2 · kind B2 · utility
8Cited by
16References
9Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Oct 12, 2001 |
| Grant date | Mar 24, 2009 |
| Priority date | — |
| Expiry date | Sep 22, 2022 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P35/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
Carnitine and other muscle protectors are useful to prevent side effects of aplidine and aplidine analogues.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.